Liquid Biopsy

An emerging healthcare market trend with expected growth and market penetration

Innovation is the application of existing technologies in new and exciting ways. KMC is applying our innovation expertise and adding value to the fields of healthcare, agriculture, animal science, and more. See how KMC can partner with you.

The benefits of liquid biopsy in the screening for diseases, post-treatment analysis, and monitoring for disease reoccurrence or progression, make it one of the emerging healthcare market trends with enormous growth and market penetration potential. Liquid biopsy’s non-invasive sampling, ability for rapid sample acquisition, and lower cost of testing make its use for health screening and early disease detection a potential breakthrough option when compared to traditional tissue biopsy.

Liquid biopsy still remains in the early stages of clinical use, but our experience in sample prep, and micro fluidics in the in-vitro diagnostic space makes KMC a uniquely qualified development partner. Contact KMC today and learn how we can partner with you.

What's your challenge?

We're standing by ready to help you bring your product to market.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.